Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

Hermann EA, Yang JX, Angelini E, Balte P, Bluemke DA, Carr J, Derlin K, Gomes AS, Habibi M, Hoffman EA, Johns C, Kawut SM, Kiely[...]

Zhang YF, Chang CE, Varghese TK Jr, Tao R, Hashibe M. Increased risks of type II diabetes among older Asian, Native Hawaiian, and Pacific Islander[...]

Liu CM, Fischer JL, Lee MJ, Mace JC, Kimple AJ, Markarian K, Alt JA, Bodner TE, Chowdhury NI, Chung SY, Eshaghian PH, Gao YA, Getz[...]